logo
Plus   Neg
Share
Email

AstraZeneca: Saracatinib Gets FDA's ODD For Idiopathic Pulmonary Fibrosis

British drug maker AstraZeneca Plc (AZN.L,AZN) announced Monday that US Food and Drug Administration has granted Orphan Drug Designation or ODD for saracatinib, a potential new medicine for the treatment of idiopathic pulmonary fibrosis or IPF.

IPF is a type of lung disease that results in scarring (fibrosis) of the lungs. It is a chronic, progressive, irreversible and usually fatal interstitial lung disease which affects approximately 100,000 people in the US.

IPF causes shortness of breath and progressive damage of the lung, resulting in life-threatening complications such as respiratory failure.

Saracatinib is an inhibitor of src kinase which regulates broad cell functions including cell growth and cell differentiation.

The potential new medicine was discovered by AstraZeneca and has previously been in clinical development in oncology.

Saracatinib has completed Phase I development. Phase II trials for saracatinib in IPF have not yet commenced.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Comcast Corp. on Thursday reported a 14 percent increase in profit for the first quarter from last year on a double-digit growth in revenues. Adjusted earnings per share for the quarter beat analysts' expectations, while revenues missed their estimates. Total customer relationships increased by 3.6 percent to 30.7 million in the quarter and include net additions of 300,000. French banking major Societe Generale's covered bond vehicle Societe Generale SFH has issued 100-million euros-covered bond as a security token on the Ethereum blockchain. In a statement, the lender said, "obligations de financement de l'habitat" or OFH Tokens, backed by covered bonds, have been rated Aaa / AAA by Moody's and Fitch and have been fully subscribed by the parent. Ford Motor Co. plans to invest $500 million in electric truck maker Rivian, the companies said Wednesday. They will also work together to develop an all-new battery electric vehicle for Ford using Rivian's skateboard platform. Ford's investment comes just months after Rivian revealed two new products, an all-electric pickup and SUV.
Follow RTT